Exemestane: Medgend

Exemestane FDA Approved Drugs

AFINITOR [Everolimus^{C₅₃H₈₃NO₁₄}]

10mg (oral tablet)

2.5mg (oral tablet)

7.5mg (oral tablet)

Novartis^{Mar 30, 2009}

Treatment of advanced hormone receptor positive, her2-negative breast cancer in combination with exemestane after failure of treatment with letrozole or anastrozole.
Treatment of patients with progessive neuroendocrine tumors of pancreatic origin (pnet) that are unresectable, locally advanced or metastatic.
Treatment of patients with tuberous sclerosis complex (tsc) who have subependymal giant cell astrocytoma (sega) that requires therapeutic intervention but cannot be curatively resected..
Treatment of solid excretory system tumors; advanced renal cell carcinoma (rcc), after failure of treatment with sunitinib or sorafenib.

efficacy
2.0 (2)

side effects
0.0 (0)

danger
0.0 (0)

AROMASIN [Exemestane^{C₂₀H₂₄O₂}]

25mg (oral tablet)

Pharmacia And Upjohn^{Oct 21, 1999}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

EXEMESTANE [Exemestane^{C₂₀H₂₄O₂}]

25mg (oral tablet)

Alvogen Malta^{Jul 28, 2014}
Mylan Pharms Inc^{Mar 10, 2017}
West-ward Pharms Int^{Apr 1, 2011}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.